Case Studies

The Chief Marketing Officer of a prescription digital therapeutics (PDT) company was seeking to prepare the organization for future launches. Read how Vynamic leveraged both Healthcare Technology and Life Sciences expertise to build a detailed, practical launch playbook used to expand commercialization in both products and patient types.

Following the acquisition of a large company, Vynamic’s global biopharmaceutical client needed to integrate the people, processes, and technology from both organizations into a new, unified Commercial Operations group. Read how Vynamic provided the collaborative leadership and deep expertise to successfully combine the organizations through enhanced ways of working and common technologies.

Following an acquisition, a global biopharmaceutical company needed to consolidate disparate brands into a single portfolio and enable a new brands director. Read how Vynamic completed a comprehensive assessment and knowledge transfer to enable the new director to lead the portfolio and implement recommended improvements.

In the midst of integrating one company from a prior deal, a mid-sized pharmaceutical organization made an additional acquisition with a narrow timeframe to complete the integration to meet contractual obligations. Read how Vynamic adapted plans and led a range of activities to meet the original target integration dates despite significant client resource constraints.

Read how a European-based regional HR organization within a Global Pharmaceutical company asked Vynamic to assess the current state of Diversity, Equity, & Inclusion (DEI) across their local countries with the goal of developing a recommended DEI operating model, strategy, and implementation plan.

While awaiting approval to launch a new product, a large pharmaceutical company identified a need to revisit their market access strategy due to various evolving external factors that could require adjustments in their launch approach. Read how Vynamic helped this client assess those factors, refresh their strategy, identify/implement recommended adjustments, and implement an ongoing performance monitoring framework that ensured they would remain nimble with the evolving market.

Vynamic brought strategic thinking, market expertise, and experience managing complex transformational programs to help a health insurer launch and test a new product. Read how the success of the fast-paced, cross-functional project led the client to exceed sales targets, overtake competitors, and establish a blueprint for future launches.

A high-impact diversity, equity, and inclusion (DEI) strategy requires an intentional approach that aligns organizational leaders around a singular vision and holds everyone accountable to it. To help give greater clarity and strategic focus to enabling such an outcomes-focused DEI strategy, read how a newly formed global life sciences organization engaged Vynamic to define the optimal organization design that would bring operational alignment to DEI as an enterprise priority.

Cyberattacks are increasingly plaguing our healthcare system due to the rapid expansion of internet-connected technology, telemedicine, and remote support staff. In 2021, 66% of healthcare organizations were hit by ransomware[1], costing an average of $10.10 million[2] and resulting in an average duration of 20 days of downtime[3]. Healthcare providers spend less than 5% of their IT budgets on security[4], making them prime targets for an attack that can cripple clinical operations, presenting risks to patient safety and quality of care. Read how Vynamic partnered with a large, urban health system to map out off-line procedures across clinical and operational departments and prepared senior leaders and the incident response team to mobilize the enterprise in the event of an attack.